Maysaa Merhi Basha1, Kushak Suchdev2, Monica Dhakar3, William J Kupsky2,4, Sandeep Mittal5, Aashit K Shah2. 1. Division of Epilepsy, Department of Neurology, Wayne State University School of Medicine, 4201 St Antoine, 8C UHC, Detroit, MI, 48201, USA. mmerhi@med.wayne.edu. 2. Division of Epilepsy, Department of Neurology, Wayne State University School of Medicine, 4201 St Antoine, 8C UHC, Detroit, MI, 48201, USA. 3. Comprehensive Epilepsy Center, Yale University, New Haven, CT, USA. 4. Department of Pathology, Wayne State University School of Medicine, Detroit, MI, USA. 5. Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA.
Abstract
BACKGROUND: To identify the role of acute surgical intervention in the treatment of refractory status epilepticus (RSE). METHODS: Retrospective review of consecutive patients who underwent epilepsy surgery from 2006 to 2015 was done to identify cases where acute surgical intervention was employed for the treatment of RSE. In addition, the adult and pediatric RSE literature was reviewed for reports of surgical treatment of RSE. RESULTS: Nine patients, aged 20-68 years, with various etiologies were identified to have undergone acute surgical resection for the treatment of RSE, aided by electrocorticography. Patients required aggressive medical therapy with antiepileptic drugs and intravenous anesthetic drugs for 10-54 days and underwent extensive neurodiagnostic testing prior to resective surgery. Eight out of nine patients survived and five patients were seizure-free at the last follow-up. The literature revealed 13 adult and 48 pediatric cases where adequate historical detail was available for review and comparison. CONCLUSIONS: We present the largest cohort of consecutive adult patients who underwent resective surgery in the setting of RSE. We also reveal that surgery can be efficacious in aborting status and in some can lead to long-term seizure freedom. Acute surgical intervention is a viable option in prolonged RSE and proper evaluation for such intervention should be conducted, although the timing and type of surgical intervention remain poorly defined.
BACKGROUND: To identify the role of acute surgical intervention in the treatment of refractory status epilepticus (RSE). METHODS: Retrospective review of consecutive patients who underwent epilepsy surgery from 2006 to 2015 was done to identify cases where acute surgical intervention was employed for the treatment of RSE. In addition, the adult and pediatric RSE literature was reviewed for reports of surgical treatment of RSE. RESULTS: Nine patients, aged 20-68 years, with various etiologies were identified to have undergone acute surgical resection for the treatment of RSE, aided by electrocorticography. Patients required aggressive medical therapy with antiepileptic drugs and intravenous anesthetic drugs for 10-54 days and underwent extensive neurodiagnostic testing prior to resective surgery. Eight out of nine patients survived and five patients were seizure-free at the last follow-up. The literature revealed 13 adult and 48 pediatric cases where adequate historical detail was available for review and comparison. CONCLUSIONS: We present the largest cohort of consecutive adult patients who underwent resective surgery in the setting of RSE. We also reveal that surgery can be efficacious in aborting status and in some can lead to long-term seizure freedom. Acute surgical intervention is a viable option in prolonged RSE and proper evaluation for such intervention should be conducted, although the timing and type of surgical intervention remain poorly defined.
Entities:
Keywords:
Acute epilepsy surgery; Continuous EEG; De novo status epilepticus; Intracranial electrodes; Refractory status epilepticus
Authors: Sarah K B Bick; Saef Izzy; Daniel B Rubin; Sahar F Zafar; Eric S Rosenthal; Emad N Eskandar Journal: Neurocrit Care Date: 2016-12 Impact factor: 3.210
Authors: Dominik Madžar; Anna Geyer; Ruben U Knappe; Stephanie Gollwitzer; Joji B Kuramatsu; Stefan T Gerner; Hajo M Hamer; Hagen B Huttner Journal: J Neurol Date: 2016-01-02 Impact factor: 4.849
Authors: Koshi A Cherian; Karen Weidenheim; Alan D Legatt; Keivan Shifteh; I Richmond Abbott; Solomon L Moshé Journal: Epilepsy Res Date: 2009-05-21 Impact factor: 3.045
Authors: Michael W Watkins; Ekta G Shah; Michael E Funke; Stephanie Garcia-Tarodo; Manish N Shah; Nitin Tandon; Fernando Maestu; Christopher Laohathai; David I Sandberg; Jeremy Lankford; Stephen Thompson; John Mosher; Gretchen Von Allmen Journal: Front Hum Neurosci Date: 2021-06-04 Impact factor: 3.169